KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Free Cash Flow (2020 - 2025)

AbCellera Biologics' Free Cash Flow history spans 6 years, with the latest figure at -$44.6 million for Q4 2025.

  • For the quarter ending Q4 2025, Free Cash Flow fell 88.68% year-over-year to -$44.6 million, compared with a TTM value of -$174.1 million through Dec 2025, up 6.89%, and an annual FY2025 reading of -$174.1 million, up 6.89% over the prior year.
  • Free Cash Flow for Q4 2025 was -$44.6 million at AbCellera Biologics, up from -$61.5 million in the prior quarter.
  • The five-year high for Free Cash Flow was $241.7 million in Q2 2022, with the low at -$139.3 million in Q3 2022.
  • Average Free Cash Flow over 5 years is -$4.5 million, with a median of -$24.9 million recorded in 2021.
  • Biggest YoY gain for Free Cash Flow was 7961.99% in 2021; the steepest drop was 11570.54% in 2021.
  • Tracing ABCL's Free Cash Flow over 5 years: stood at -$26.1 million in 2021, then soared by 171.08% to $18.6 million in 2022, then plummeted by 283.2% to -$34.0 million in 2023, then surged by 30.59% to -$23.6 million in 2024, then crashed by 88.68% to -$44.6 million in 2025.
  • Per Business Quant, the three most recent readings for ABCL's Free Cash Flow are -$44.6 million (Q4 2025), -$61.5 million (Q3 2025), and -$45.8 million (Q2 2025).